• Online First:
    3articles
    Sort by
    Latest
    Open Access
    Review
    Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
    The dismal prognosis of recurrent/metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) prompted recent advances in the field of therapeutic approaches beyond cytotoxic cancer therapy. In r...
    Stefano Cavalieri ... Laura D. Locati
    Online First: December 07, 2021 Explor Target Antitumor Ther. 2021;2:Online First
    DOI: https://doi.org/10.37349/etat.2021.00062
    This article belongs to the special issue Immunotherapy in Cancer Patients
    View:63
    Download:8
    Times Cited: 0
    Open Access
    Review
    The clinical advances of proteolysis targeting chimeras in oncology
    Proteolysis targeting chimeras (PROTACs) are a class of small molecules designed to target proteins for degradation. Their novel and unique modes of action provide PROTACs with the potential for the...
    Hao Xie ... Jason B. Fleming
    Online First: December 02, 2021 Explor Target Antitumor Ther. 2021;2:Online First
    DOI: https://doi.org/10.37349/etat.2021.00061
    This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
    View:88
    Download:20
    Times Cited: 0
    Open Access
    Review
    Proteolysis-targeting chimeras and their implications in breast cancer
    Breast cancer (BC) is a highly heterogeneous neoplasm of the mammary tissue, causing the deaths of a large number of women worldwide. Nearly 70% and 20% of BC cases are estro...
    Angeles C. Tecalco-Cruz ... Alberto Rojas-Ochoa
    Online First: November 16, 2021 Explor Target Antitumor Ther. 2021;2:Online First
    DOI: https://doi.org/10.37349/etat.2021.00060
    This article belongs to the special issue Proteolysis Targeting Chimera (PROTAC)
    View:173
    Download:32
    Times Cited: 0